HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jian-Hua Ding Selected Research

N- (1- methylethyl)- 1,1,2- trimethylpropylamine

9/2014Iptakalim confers an antidepressant effect in a chronic mild stress model of depression through regulating neuro-inflammation and neurogenesis.
4/2009Iptakalim ameliorates MPP+-induced astrocyte mitochondrial dysfunction by increasing mitochondrial complex activity besides opening mitoK(ATP) channels.
12/2007Iptakalim alleviates rotenone-induced degeneration of dopaminergic neurons through inhibiting microglia-mediated neuroinflammation.
6/2006Protective effects of iptakalim, a novel ATP-sensitive potassium channel opener, on global cerebral ischemia-evoked insult in gerbils.
5/2005Systematic administration of iptakalim, an ATP-sensitive potassium channel opener, prevents rotenone-induced motor and neurochemical alterations in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jian-Hua Ding Research Topics

Disease

20Parkinson Disease (Parkinson's Disease)
01/2021 - 05/2005
10Neuroinflammatory Diseases
10/2019 - 12/2007
8Breast Neoplasms (Breast Cancer)
01/2015 - 01/2009
6Inflammation (Inflammations)
09/2018 - 01/2014
6Colorectal Neoplasms (Colorectal Cancer)
01/2014 - 11/2007
5Neurodegenerative Diseases (Neurodegenerative Disease)
09/2018 - 05/2005
4Stroke (Strokes)
01/2019 - 06/2006
3Brain Diseases (Brain Disorder)
10/2019 - 08/2013
3Ischemic Stroke
01/2019 - 09/2008
3Neoplasms (Cancer)
05/2016 - 11/2007
2Brain Ischemia (Cerebral Ischemia)
01/2019 - 06/2006
2Rectal Neoplasms (Rectal Cancer)
01/2012 - 11/2007
2Stomach Neoplasms (Stomach Cancer)
01/2010 - 04/2004
2Substance-Related Disorders (Drug Abuse)
07/2009 - 04/2006
2Colonic Neoplasms (Colon Cancer)
04/2008 - 11/2007
2Ischemia
06/2006 - 05/2005
2Catalepsy
06/2005 - 05/2005
1Insulin Resistance
01/2019
1Reperfusion Injury
01/2019
1Dyskinesias (Dyskinesia)
01/2017
1Synucleinopathies
12/2016
1Ascites
05/2016
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2016
1Myopia
01/2015
1Liver Diseases (Liver Disease)
04/2014
1Type 2 Diabetes Mellitus (MODY)
01/2014
1Schizophrenia (Dementia Praecox)
12/2012
1AIDS-Related Complex (ARC)
12/2012
1Nerve Degeneration
09/2012
1Nervous System Diseases (Neurological Disorders)
01/2012
1Body Weight (Weight, Body)
01/2011
1Cocaine-Related Disorders (Cocaine Addiction)
07/2009
1Esophageal Neoplasms (Esophageal Cancer)
05/2009
1Mitochondrial Diseases (Mitochondrial Disease)
04/2009

Drug/Important Bio-Agent (IBA)

15Adenosine Triphosphate (ATP)IBA
10/2019 - 09/2005
8InflammasomesIBA
01/2019 - 02/2014
61- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
10/2019 - 04/2009
6ORALIT (ORS)IBA
01/2014 - 04/2004
5PotassiumIBA
10/2019 - 09/2005
5Proteins (Proteins, Gene)FDA Link
09/2018 - 02/2005
5N- (1- methylethyl)- 1,1,2- trimethylpropylamineIBA
09/2014 - 05/2005
5RotenoneIBA
09/2008 - 05/2005
5KATP ChannelsIBA
06/2006 - 05/2005
4SynucleinsIBA
09/2018 - 01/2014
4Neuroprotective AgentsIBA
01/2018 - 12/2007
4Dopamine (Intropin)FDA LinkGeneric
01/2015 - 05/2005
4Glutamic Acid (Glutamate)FDA Link
06/2006 - 02/2005
3NLR ProteinsIBA
04/2016 - 02/2014
3Folic Acid (Vitamin M)FDA LinkGeneric
07/2009 - 04/2004
2Reactive Oxygen Species (Oxygen Radicals)IBA
10/2019 - 09/2012
2Growth Hormone (Somatotropin)IBA
01/2015 - 03/2010
2Thymidylate SynthaseIBA
01/2012 - 04/2004
2AldehydesIBA
01/2010 - 05/2009
2Cocaine (Cocaine HCl)IBA
07/2009 - 04/2006
2Oxidoreductases (Dehydrogenase)IBA
07/2009 - 07/2009
2Diazoxide (Hyperstat)FDA Link
09/2008 - 05/2005
2Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
04/2008 - 04/2004
2Messenger RNA (mRNA)IBA
02/2006 - 02/2005
1Complement System Proteins (Complement)IBA
01/2021
1LipopolysaccharidesIBA
01/2021
1astragaloside AIBA
04/2020
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
09/2018
1QuinpiroleIBA
09/2018
1MAP kinase kinase kinase 7IBA
09/2018
1GTP-Binding Proteins (G-Protein)IBA
09/2018
1CaspasesIBA
01/2017
1Probenecid (Benemid)FDA LinkGeneric
01/2017
1PyrrolidinesIBA
01/2017
1Caspase 7IBA
01/2017
1Adenosine Triphosphatases (ATPase)IBA
01/2016
1InterferonsIBA
01/2016
1ginkgolide BIBA
01/2016
1Interleukin-4 (Interleukin 4)IBA
01/2016
1Biological ProductsIBA
01/2016
11-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA
01/2016
1Adenosine (Adenocard)FDA LinkGeneric
12/2015
1Retinaldehyde (Retinal)IBA
01/2015
1Caspase 1 (ICE Protease)IBA
09/2014
1Antidepressive Agents (Antidepressants)IBA
09/2014
1InterleukinsIBA
09/2014
1Transcription Factor CHOPIBA
02/2014
1Caspase 12IBA
02/2014
1Fatty Acids (Saturated Fatty Acids)IBA
01/2014
1Codon (Codons)IBA
01/2014
1Tobacco Smoke Pollution (Passive Smoking)IBA
01/2013
1Dizocilpine Maleate (Dizocilpine)IBA
12/2012
1Uncoupling Protein 2IBA
09/2012
1Serine (L-Serine)FDA Link
01/2012
13' Untranslated Regions (3' UTR)IBA
01/2012
15' Untranslated Regions (5' UTR)IBA
01/2012
1Sucrose (Saccharose)IBA
01/2011
1Connexin 43 (Connexin43)IBA
01/2011
15,10-methylenetetrahydrofolic acidIBA
07/2009
1Aquaporin 4IBA
07/2009
1mitochondrial K(ATP) channelIBA
04/2009
1ProstaglandinsIBA
09/2008
1Pinacidil (Pindac)FDA Link
09/2008

Therapy/Procedure

2Therapeutics
09/2018 - 09/2014
1Laparotomy
05/2016
1Induced Abortion (Induced Abortions)
01/2012